| 1. | Vaccines have been developed to protect against which hepatitis viruses? |
| A. | Hepatitis A & E |
| B. | Hepatitis A & B |
| C. | Hepatitis B & C |
| D. | Hepatitis C & D |
| E. | Hepatitis D & E |
| 2. | The rate of chronicity of hepatitis B virus infection is highest at which stage? |
| A. | At birth or during the first year of life |
| B. | Children aged 1 - 6 years |
| C. | Children above 6 years of age |
| D. | In adults |
| E. | None of above |
| 3. | Which of the following about Herpes Zoster is TRUE? |
| A. | Post herpetic neuralgia is a rare complication of Herpes Zoster. |
| B. | The estimated overall incidence of Herpes Zoster increases with age, especially in those aged over 80 years. |
| C. | Herpes Zoster is a reactivation of the latent Varicella Zoster virus infection in the motor nerve ganglion. |
| D. | The burden of illness of Herpes Zoster infection is not a concern in developed countries. |
| E. | Herpes Zoster vaccine can reduce the risk of having Herpes Zoster but it cannot reduce the incidence of post-herpetic neuralgia. |
| 4. | Which of the following about Herpes Zoster vaccine is TRUE? (I) In 2011, the US Food and Drug Administration approved the use of this vaccination for adults >18 year-old. (II) The Herpes Zoster vaccine reduced the risk of post-herpetic neuralgia. (III) There were a few studies showing that the Herpes Zoster vaccine acceptance rate was higher in patients with a history of influenza vaccination. (IV) The Herpes Zoster vaccine is not registered in Hong Kong. |
| A. | (I) and (II) |
| B. | (II) and (III) |
| C. | (I), (III) and (IV) |
| D. | (I), (II) and (III) |
| E. | (I), (II), (III) and (IV) |
| 5. | For the diagnosis of rosacea, which one of the followings is a diagnostic phenotype: |
| A. | Papules and pustules |
| B. | Telangiectasia |
| C. | Ocular manifestations |
| D. | Phymatous changes |
| E. | Burning or stinging |
| 6. | Concerning the treatment of rosacea, which one of the following statements is NOT TRUE: |
| A. | The use of cosmetic camouflage is considered as a general non-pharmacological measure for the treatment of rosacea. |
| B. | Light-based modalities do not cure rosacea, and periodic treatments to maintain improvement are often required. |
| C. | The mechanism through which metronidazole improves rosacea is well proven to be solely due to its antimicrobial property. |
| D. | Tetracyclines are the best-studied agents amongst the oral antibiotics used to treat rosacea. |
| E. | Patients with signs or symptoms of ocular involvement should be referred to an ophthalmologist for further evaluation. |